Download Files:
96 CAD – 1,253 CADPrice range: 96 CAD through 1,253 CAD
Products Details
Product Description
– AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM). It reduces toxic galactitol levels and prevents disease complications in GALT deficiency rats.
Web ID
– T10393
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C17H10F3N3O3S2
References
– Maeve Conneighton, et al. Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia.
CAS Number
– 2170729-29-8
Molecular Weight
– C17H10F3N3O3S2
Compound Purity
– 0.9936
SMILES
– OC(=O)Cc1nn(Cc2nc3cc(ccc3s2)C(F)(F)F)c(=O)c2cscc12
Target
– Others
Pathway
– Endocrinology/Hormones|||Metabolism
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock

